成体幹細胞の市場規模、シェア、動向分析レポート：タイプ別、製品・サービス別、適応症別、用途別、最終用途別、セグメント予測、2024年～2030年

成体幹細胞の市場規模と動向

成体幹細胞の世界市場規模は、2023年に123億5,000万米ドルと評価され、いくつかの重要な要因によって、2024年から2030年にかけてCAGR 11.2％で成長すると予測されています。様々な組織や臓器に存在するこれらの細胞は、再生医療や治療への応用に計り知れない可能性を秘めています。成体幹細胞治療の研究開発（R&D）は、バイオテクノロジーと分子生物学の進歩に後押しされる形で活発化しています。

科学者たちは、成体幹細胞の新たな供給源を探索し、培養技術を最適化し、特殊な細胞種への分化方法を改良しています。例えば、ボストン小児病院は、正常な肺と肺がんに罹患した肺の両方から肺幹細胞を分離するなど、成体幹細胞研究で重要なマイルストーンを達成しました。このような技術革新は、心血管疾患から神経疾患まで、幅広い疾患や傷害の治療に応用できる可能性を広げています。

市場の最も重要な促進要因のひとつは、研究開発への投資の増加です。製薬会社、バイオテクノロジー企業、学術機関は、様々な医療用途における成体幹細胞の治療可能性を探るために、多大なリソースを割いています。例えば、インドのバイオテクノロジー省（DBT）は、2019年から2022年にかけて、幹細胞研究の多くの分野におけるイニシアチブを積極的に支援しています。これらのイニシアティブには、基礎的な生物学的洞察、トランスレーショナルリサーチプロジェクト、電力や臨床応用のための遺伝学的変換技術などが含まれます。この期間中、DBTはこれらのプロジェクトに880万米ドルを拠出しました。これらの投資は、前臨床研究、臨床試験、拡張可能な製造プロセスの開発を支援します。

CRISPR-Cas9遺伝子編集や人工多能性幹細胞（iPSC）などの先端技術は、幹細胞を効果的に操作・利用する研究者の能力を高めています。研究開発努力が有望な成果を生み出し、規制の枠組みが進化するにつれて、市場は拡大し、複雑な疾患を治療し、患者の予後を改善するための革新的なソリューションを世界的に提供する態勢が整いつつあります。

加えて、慢性疾患の増加が市場成長の大きな促進要因となっています。糖尿病、心血管疾患、神経変性疾患などの疾患は、人口の高齢化とライフスタイルの要因により増加しています。CDCが2024年2月に発表した報告書によると、米国ではおよそ1億2,900万人が少なくとも1つの重大な慢性疾患の影響を受けています。成体幹細胞は、このような疾病の根本的な原因に対処できる可能性のある治療法であり、従来の治療法では対応できないような再生可能な解決策を提供します。ヘルスケアシステムが慢性疾患の管理により効果的で個別化されたアプローチを模索するにつれ、成体幹細胞治療に対する需要は拡大し、研究開発や臨床現場での採用が促進されると予想されます。

さらに、世界中の規制機関は、成体幹細胞治療の安全性、有効性、倫理的な使用を確保するためのガイドラインを策定しています。承認プロセスが合理化され、規制の道筋が明確になることで、商業化や市場拡大への投資が促進され、患者が先進的な治療法を利用しやすくなります。

世界の成人幹細胞市場レポートセグメンテーション

本レポートでは、2018年から2030年にかけての収益成長を国レベルで予測し、各サブセグメントにおける最新の業界動向と収益機会に関する分析を提供しています。本調査の目的で、Grand View Research社は世界の成人幹細胞市場レポートをタイプ、製品＆サービス、適応症、用途、最終用途、地域に基づいてセグメント化しています。

• タイプの展望（売上高、2018年～2030年）。
• 自家成体幹細胞。
• 同種成体幹細胞。
• 製品・サービスの展望（売上高、2018年～2030年）。
• 製品。

キット、培地、試薬

細胞および細胞株

造血系

間葉系

神経系

上皮/皮膚

その他

サービス

• 適応症の展望（売上高、2018年～2030年）。
• 骨・軟骨修復。
• 心血管疾患。
• 炎症および免疫疾患。
• 肝疾患。
• がん。
• GvHD。
• その他。
• 用途の展望（売上高、2018年～2030年）。
• 治療薬。
• 疾患モデリング。
• 医薬品開発・発見。
• 毒物学研究。
• バイオバンク。
• 組織工学
• その他
• 最終用途の展望（売上高、2018年～2030年）。
• バイオ製薬会社。
• 研究機関。
• 病院および診療所。
• 地域別展望（売上高、2018年～2030年）。
• 北米。

米国

カナダ

メキシコ

• 欧州

英国

ドイツ

フランス

イタリア

スペイン

ノルウェー

デンマーク

スウェーデン

• アジア太平洋

日本

中国

インド

オーストラリア

韓国

タイ

• ラテンアメリカ

ブラジル

アルゼンチン

• 中東＆アフリカ

南アフリカ

サウジアラビア

アラブ首長国連邦

クウェート

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 成体幹細胞市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
• 成体幹細胞市場分析ツール

第4章 成体幹細胞市場：タイプ推定・動向分析

• セグメントダッシュボード
• 成体幹細胞市場：タイプ変動分析
• 成体幹細胞市場タイプ別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 自己成体幹細胞
• 同種成体幹細胞

第5章 成体幹細胞市場：製品・サービスの推定・動向分析

• セグメントダッシュボード
• 成体幹細胞市場：製品・サービスの変動分析
• 成体幹細胞市場：製品・サービス別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 製品

5.5.3.2.1.造血器市場収益推計と予測、2018年-2030年

5.5.3.3.1.間葉系市場収益推計と予測、2018年-2030年

5.5.3.4.1.ニューラル市場収益推計と予測、2018年-2030年

5.5.3.5.1.上皮/皮膚市場収益推計と予測、2018年-2030年

5.5.3.6.1.その他市場収益推計および予測、2018年-2030年

• サービス
  • サービス市場収益推計と予測、2018年-2030年

第6章 成体幹細胞市場：適応症の推定・動向分析

• セグメントダッシュボード
• 成体幹細胞市場：適応症変動分析
• 成人幹細胞市場の適応症別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 骨と軟骨の修復
• 心血管疾患
• 炎症性および免疫性疾患
• 肝臓疾患
• がん
• 移植片対宿主障害
• その他

第7章 成体幹細胞市場：用途推定・動向分析

• セグメントダッシュボード
• 成体幹細胞市場：用途変動分析
• 成体幹細胞市場- 用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 治療薬
• 疾患モデル
• 医薬品開発と発見
• 毒性学研究
• バイオバンキング
• 組織工学
• その他

第8章 成体幹細胞市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 成体幹細胞市場：最終用途変動分析
• 最終用途別成体幹細胞市場展望
• 2018年から2030年までの市場規模と予測および動向分析
• バイオ医薬品企業
• 研究機関
• 病院・クリニック

第9章 成体幹細胞市場：地域推定・動向分析

• 地域ダッシュボード
• 地域別成体幹細胞市場変動分析
• 成体幹細胞市場：タイプ、製品、サービス、最終用途別の地域推定・動向分析
• 2018年から2030年までの市場規模と予測および動向分析
• 北米
  • 北米市場推計・予測2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 2018年から2030年までの欧州市場推計・予測
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋市場推計・予測2018～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ市場推計・予測2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ市場推計・予測2018年から2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 市場参入企業の分類
• 主要企業の市況分析、2023年
• 主要企業プロファイル
  • Thermo Fisher Scientific, Inc
  • STEMCELL Technologies
  • Osiris Therapeutics
  • ZenBio, Inc.
  • Stempeutics Research
  • Fate Therapeutics, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Stemedica Cell Technologies, Inc.
  • Vericel Corporation

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 4. Global adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 5. Global adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 6. Global adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 7. Global adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 8. North America adult stem cells market, by region, 2018 - 2030 (USD Million)
• Table 9. North America adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 10. North America adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 11. North America adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 12. North America adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 13. North America adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 14. U.S. adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 15. U.S. adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 16. U.S. adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 17. U.S. adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 18. U.S. adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 19. Canada adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 20. Canada adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 21. Canada adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 22. Canada adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 23. Canada adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 24. Mexico adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 25. Mexico adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 26. Mexico adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 27. Mexico adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 28. Mexico adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 29. Europe adult stem cells market, by country, 2018 - 2030 (USD Million)
• Table 30. Europe adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 31. Europe adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 32. Europe adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 33. Europe adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 34. Europe adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 35. UK adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 36. UK adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 37. UK adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 38. UK adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 39. UK adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 40. Germany adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 41. Germany adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 42. Germany adult stem cells market, by indication 2018 - 2030 (USD Million)
• Table 43. Germany adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 44. Germany adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 45. France adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 46. France adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 47. France adult stem cells market, by indication 2018 - 2030 (USD Million)
• Table 48. France adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 49. France adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 50. Italy adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 51. Italy adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 52. Italy adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 53. Italy adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 54. Italy adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 55. Spain adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 56. Spain adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 57. Spain adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 58. Spain adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 59. Spain adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 60. Denmark adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 61. Denmark adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 62. Denmark adult stem cells market, by indication 2018 - 2030 (USD Million)
• Table 63. Denmark adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 64. Denmark adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 65. Norway adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 66. Norway adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 67. Norway adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 68. Norway adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 69. Norway adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 70. Sweden adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 71. Sweden adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 72. Sweden adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 73. Sweden adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 74. Sweden adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 75. Asia Pacific adult stem cells market, by country, 2018 - 2030 (USD Million)
• Table 76. Asia Pacific adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 77. Asia Pacific adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 78. Asia Pacific adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 79. Asia Pacific adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 80. Asia Pacific adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 81. Japan adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 82. Japan adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 83. Japan adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 84. Japan adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 85. Japan adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 86. China adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 87. China adult stem cells market, by product & services 2018 - 2030 (USD Million)
• Table 88. China adult stem cells market, by indication 2018 - 2030 (USD Million)
• Table 89. China adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 90. China adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 91. India adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 92. India adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 93. India adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 94. India adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 95. India adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 96. Australia adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 97. Australia adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 98. Australia adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 99. Australia adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 100. Australia adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 101. South Korea adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 102. South Korea adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 103. South Korea adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 104. South Korea adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 105. South Korea adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 106. Thailand adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 107. Thailand adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 108. Thailand adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 109. Thailand adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 110. Thailand adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 111. Latin America adult stem cells market, by country, 2018 - 2030 (USD Million)
• Table 112. Latin America adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 113. Latin America adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 114. Latin America adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 115. Latin America adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 116. Latin America adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 117. Brazil adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 118. Brazil adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 119. Brazil adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 120. Brazil adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 121. Brazil adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 122. Argentina adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 123. Argentina adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 124. Argentina adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 125. Argentina adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 126. Argentina adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 127. Middle East & Africa adult stem cells market, by country, 2018 - 2030 (USD Million)
• Table 128. Middle East & Africa adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 129. Middle East & Africa adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 130. Middle East & Africa adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 131. Middle East & Africa adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 132. Middle East & Africa adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 133. South Africa adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 134. South Africa adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 135. South Africa adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 136. South Africa adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 137. South Africa adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 138. Saudi Arabia adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 139. Saudi Arabia adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 140. Saudi Arabia adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 141. Saudi Arabia adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 142. Saudi Arabia adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 143. UAE adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 144. UAE adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 145. UAE adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 146. UAE adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 147. UAE adult stem cells market, by end use, 2018 - 2030 (USD Million)
• Table 148. Kuwait adult stem cells market, by type, 2018 - 2030 (USD Million)
• Table 149. Kuwait adult stem cells market, by product & services, 2018 - 2030 (USD Million)
• Table 150. Kuwait adult stem cells market, by indication, 2018 - 2030 (USD Million)
• Table 151. Kuwait adult stem cells market, by application, 2018 - 2030 (USD Million)
• Table 152. Kuwait adult stem cells market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig 1. Adult stem cells market segmentation
• Fig 2. Data analysis models
• Fig 3. Market formulation and validation
• Fig 4. Data validating & publishing
• Fig 5. Market research process
• Fig 6. Information procurement
• Fig 7. Primary research
• Fig 8. Value-chain-based sizing & forecasting
• Fig 9. QFD modelling for market share assessment
• Fig 10. Market formulation & validation
• Fig 11. Commodity flow analysis
• Fig 12. Market outlook
• Fig 13. Segment snapshot-1
• Fig 14. Segment snapshot-2
• Fig 15. Competitive landscape snapshot
• Fig 16. Market trends & outlook
• Fig 17. Porter's five force analysis
• Fig 18. PESTEL analysis
• Fig 19. Adult stem cells market, type outlook key takeaways (USD Million)
• Fig 20. Adult stem cells market: type movement analysis (USD Million), 2023 & 2030
• Fig 21. Autologous adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 22. Allogeneic adult stem cells market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 23. Adult stem cells market, product & services outlook key takeaways (USD Million)
• Fig 24. Adult stem cells market: product & services movement analysis (USD Million), 2023 & 2030
• Fig 25. Product market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 26. Kits, media, & reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 27. Cells & cell lines market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 28. Hematopoietic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 29. Mesenchymal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 30. Neural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 31. Epithelial/Skin market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 32. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 33. Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 34. Adult stem cells market, indication outlook key takeaways (USD Million)
• Fig 35. Adult stem cells market: indication movement analysis (USD Million), 2023 & 2030
• Fig 36. Bone and cartilage repair market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 37. Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 38. Inflammatory and immunological diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 39. Liver diseases market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 40. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 41. GvHD market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 42. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 43. Adult stem cells market, application outlook key takeaways (USD Million)
• Fig 44. Adult stem cells market: application movement analysis (USD Million), 2023 & 2030
• Fig 45. Therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 46. Disease modeling market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 47. Drug development & discovery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 48. Toxicology studies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 49. Biobanking market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 50. Tissue engineering market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 51. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 52. Adult stem cells market, end use outlook key takeaways (USD Million)
• Fig 53. Adult stem cells market: end use movement analysis (USD Million), 2023 & 2030
• Fig 54. Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 55. Research institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 56. Biopharmaceutical companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 57. Adult stem cells market: regional key takeaways (USD Million)
• Fig 58. Adult stem cells market: regional outlook, 2023 & 2030, USD billion
• Fig 59. North America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 60. U.S. adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 61. Canada adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 62. Mexico adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 63. Europe adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 64. UK adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 65. Germany adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 66. France adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 67. Spain adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 68. Italy adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 69. Norway adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 70. Denmark adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 71. Sweden adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 72. Asia Pacific adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 73. China adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 74. Japan adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 75. India adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 76. South Korea adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 77. Australia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 78. Thailand adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 79. Latin America adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 80. Brazil adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 81. Argentina adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 82. Middle East and Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 83. South Africa adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 84. Saudi Arabia adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 85. UAE adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 86. Kuwait adult stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 87. List of key emerging company's/technology disruptors/innovators

Adult Stem Cells Market Size & Trends

The global adult stem cells market size was valued at USD 12.35 billion in 2023 and is projected to grow at a CAGR of 11.2% from 2024 to 2030, driven by several key factors. These cells, found in various tissues and organs, hold immense potential for regenerative medicine and therapeutic applications. As research continues to uncover their capabilities, the market is poised for significant expansion in the coming years.Research and development (R&D) efforts in adult stem cell therapies have intensified, propelled by advances in biotechnology and molecular biology.

Scientists are exploring new sources of adult stem cells, optimizing culture techniques, and refining methods for differentiation into specialized cell types. For instance, Boston Children's Hospital has achieved significant milestones in adult stem cell research, including the isolation of lung stem cells from both normal lungs and those affected by lung cancer. These innovations are expanding the scope of potential applications in treating a wide range of diseases and injuries, from cardiovascular disorders to neurological conditions.

One of the most important drivers of the market is the increasing investment in research and development. Pharmaceutical companies, biotechnology firms, and academic institutions are allocating significant resources to explore the therapeutic potential of adult stem cells across various medical applications. For instance, the Department of Biotechnology (DBT) in India is actively supporting initiatives in many areas of stem cell research from 2019 to 2022. These initiatives include fundamental biological insights, translational research projects, and genetics conversion technologies for power and clinical applications. During this period, DBT committed USD 8.80 million to these projects. These investments support preclinical studies, clinical trials, and the development of scalable manufacturing processes.

Advanced technologies such as CRISPR-Cas9 gene editing and induced pluripotent stem cells (iPSCs) are enhancing researchers' ability to manipulate and utilize stem cells effectively. As R&D efforts yield promising results and regulatory frameworks evolve, the market is poised to expand, offering innovative solutions for treating complex diseases and improving patient outcomes globally.

In addition, the increasing prevalence of chronic diseases represents a significant driver of market growth. Conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders are rising due to aging populations and lifestyle factors. As per the February 2024 report released by the CDC, roughly 129 million individuals in the U.S. are impacted by at least one significant chronic illness. Adult stem cells offer potential therapies that can address the underlying causes of these diseases, providing regenerative solutions that traditional treatments often cannot match. As healthcare systems seek more effective and personalized approaches to managing chronic conditions, the demand for adult stem cell therapies is expected to grow, fueling further research, development, and adoption in clinical settings.

Furthermore, regulatory agencies worldwide are establishing guidelines to ensure the safety, efficacy, and ethical use of adult stem cell therapies. Streamlined approval processes and clearer regulatory pathways encourage investment in commercialization and market expansion, facilitating patient access to advanced treatment options.

Global Adult Stem Cells Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global adult stem cells market report based on type, product & services, indication, application, end use, and region.

• Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Autologous Adult Stem Cells
• Allogeneic Adult Stem Cells
• Product & Services Outlook (Revenue, USD Billion, 2018 - 2030)
• Product

Kits, Media, & Reagents

Cells & cell lines

Hematopoietic

Mesenchymal

Neural

Epithelial/Skin

Others

Services

• Indication Outlook (Revenue, USD Billion, 2018 - 2030)
• Bone and Cartilage Repair
• Cardiovascular Diseases
• Inflammatory and Immunological Diseases
• Liver diseases
• Cancer
• GvHD
• Others
• Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Therapeutics
• Disease Modeling
• Drug Development & Discovery
• Toxicology Studies
• Biobanking
• Tissue Engineering
• Others
• End Use Outlook (Revenue, USD Billion, 2018 - 2030)
• Biopharmaceutical Companies
• Research Institutes
• Hospitals & Clinics
• Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Norway

Denmark

Sweden

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product & Services
  • 1.2.3. Indication
  • 1.2.4. Application
  • 1.2.5. End Use
  • 1.2.6. Regional Scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights

Chapter 3. Adult Stem Cells Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Adult stem cells market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Adult Stem Cells Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Adult stem cells market: Type Movement Analysis
• 4.3. Adult stem cells market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Autologous Adult Stem Cells
  • 4.5.1. Autologous Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Allogeneic Adult Stem Cells
  • 4.6.1. Allogeneic Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Adult Stem Cells Market: Product & Services Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Adult stem cells market: Product & Services Movement Analysis
• 5.3. Adult stem cells market by Product & Services Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Product
  • 5.5.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Kits, Media, & Reagents
    • 5.5.2.1. Kits, Media, & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Cells & Cell Lines
    • 5.5.3.1. Cells & Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3.2. Hematopoietic

5.5.3.2.1. Hematopoietic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.3. Mesenchymal

5.5.3.3.1. Mesenchymal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.4. Neural

5.5.3.4.1. Neural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.5. Epithelial/Skin

5.5.3.5.1. Epithelial/Skin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.6. Others

5.5.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.6. Services
  • 5.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Adult Stem Cells Market: Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Adult stem cells market: Indication Movement Analysis
• 6.3. Adult stem cells market by Indication Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Bone and Cartilage Repair
  • 6.5.1. Bone and Cartilage Repair Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cardiovascular Diseases
  • 6.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Inflammatory and Immunological Diseases
  • 6.7.1. Inflammatory and Immunological Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Liver Diseases
  • 6.8.1. Liver Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Cancer
  • 6.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. GvHD
  • 6.10.1. GvHD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.11. Others
  • 6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Adult Stem Cells Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Adult stem cells market: Application Movement Analysis
• 7.3. Adult stem cells market by Application Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Therapeutics
  • 7.5.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Disease Modeling
  • 7.6.1. Disease Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Drug Development & Discovery
  • 7.7.1. Drug Development & Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Toxicology Studies
  • 7.8.1. Toxicology Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Biobanking
  • 7.9.1. Biobanking Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.10. Tissue Engineering
  • 7.10.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.11. Others
  • 7.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Adult Stem Cells Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Adult stem cells market: End Use Movement Analysis
• 8.3. Adult stem cells market by End Use Outlook (USD Million)
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. Biopharmaceutical Companies
  • 8.5.1. Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Research Institutes
  • 8.6.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Hospitals & Clinics
  • 8.7.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Adult Stem Cells Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Regional Adult stem cells market movement analysis
• 9.3. Adult stem cells market: Regional Estimates & Trend Analysis by Type, Product & Services & End-use
• 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 9.5. North America
  • 9.5.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Competitive scenario
    • 9.6.4.3. Regulatory framework
    • 9.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Competitive scenario
    • 9.6.5.3. Regulatory framework
    • 9.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Competitive scenario
    • 9.6.6.3. Regulatory framework
    • 9.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Denmark
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Competitive scenario
    • 9.6.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Sweden
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Competitive scenario
    • 9.6.8.3. Regulatory framework
    • 9.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.9. Norway
    • 9.6.9.1. Key country dynamics
    • 9.6.9.2. Competitive scenario
    • 9.6.9.3. Regulatory framework
    • 9.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Japan
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. China
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. India
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. Australia
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. South Korea
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Competitive scenario
    • 9.7.6.3. Regulatory framework
    • 9.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.7. Thailand
    • 9.7.7.1. Key country dynamics
    • 9.7.7.2. Competitive scenario
    • 9.7.7.3. Regulatory framework
    • 9.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Brazil
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Competitive scenario
    • 9.8.2.3. Regulatory framework
    • 9.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.3. Argentina
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Competitive scenario
    • 9.8.3.3. Regulatory framework
    • 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. South Africa
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Competitive scenario
    • 9.9.2.3. Regulatory framework
    • 9.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. Saudi Arabia
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Competitive scenario
    • 9.9.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. UAE
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Competitive scenario
    • 9.9.4.3. Regulatory framework
    • 9.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.5. Kuwait
    • 9.9.5.1. Key country dynamics
    • 9.9.5.2. Competitive scenario
    • 9.9.5.3. Regulatory framework
    • 9.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Key Company Market Position Analysis, 2023
• 10.3. Key Company Profiles
  • 10.3.1. Thermo Fisher Scientific, Inc
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Product benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. STEMCELL Technologies
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Product benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. Osiris Therapeutics
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. ZenBio, Inc.
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Stempeutics Research
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Fate Therapeutics, Inc.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. BrainStorm Cell Therapeutics Inc.
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Celgene Corporation
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Stemedica Cell Technologies, Inc.
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Vericel Corporation
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives